0001534122-15-000013.txt : 20150203 0001534122-15-000013.hdr.sgml : 20150203 20150202182148 ACCESSION NUMBER: 0001534122-15-000013 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150203 DATE AS OF CHANGE: 20150202 EFFECTIVENESS DATE: 20150203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cell MedX Corp. CENTRAL INDEX KEY: 0001493712 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 383939625 STATE OF INCORPORATION: NV FISCAL YEAR END: 0530 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-233326 FILM NUMBER: 15568682 BUSINESS ADDRESS: STREET 1: 4575 DEAN MARTIN DRIVE, SUITE 2206 CITY: LAS VEGAS STATE: NV ZIP: 89103 BUSINESS PHONE: (310) 508-9398 MAIL ADDRESS: STREET 1: 4575 DEAN MARTIN DRIVE, SUITE 2206 CITY: LAS VEGAS STATE: NV ZIP: 89103 FORMER COMPANY: FORMER CONFORMED NAME: Sports Asylum, Inc. DATE OF NAME CHANGE: 20140324 FORMER COMPANY: FORMER CONFORMED NAME: Plandel Resources, Inc. DATE OF NAME CHANGE: 20100608 D 1 primary_doc.xml X0707 D LIVE 0001493712 Cell MedX Corp. 4575 DEAN MARTIN DRIVE, SUITE 2206 LAS VEGAS NV NEVADA 89103 (310) 508-9398 NEVADA Sports Asylum, Inc. Plandel Resources, Inc. Corporation true 2010 FRANK E MCENULTY 4575 Dean Martin Drive, Suite 2206 Las Vegas NV NEVADA 89103 Executive Officer Director JEAN M ARNETT 121-3989 Henning Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5C 6P8 Executive Officer Director BRADLEY S HARGREAVES 121-3989 Henning Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5C 6P8 Executive Officer YANIKA SILINA 789 West Pender Street, Unit 810 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer JOHN SANDERSON 9 Islandview Irvine CA CALIFORNIA 92604 Executive Officer Biotechnology Decline to Disclose 06b false 2014-11-12 false true true false 0 195000 195000 0 Convertible notes, payable on demand, bear interest at 6% per annum, compounded monthly. At the discretion of the noteholder, the principal amount outstanding and accrued interest may be converted into shares of Issuer's common stock at $0.50 per share. false 1 0 0 140313 Proceeds used to pay for asset purchase from Ms. Arnett and Mr. Hargreaves prior to them becoming officers and directors and for consulting fees to Ms. Arnett and Mr. Hargreaves. false Cell MedX Corp. Yana Silina Yana Silina Chief Financial Officer 2015-02-02